GARIANE GUNTER: Open Payments
NPI 1386774974 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,623 in 91 payments from 7 companies in 2025. Trend: 2023 $597 · 2024 $8,805 · 2025 $34,623
Speaker / faculty: $31,850Travel & lodging: $1,540Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $34,226 |
| Neurocrine BioSciences, Inc. | 13 | $175 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Lundbeck LLC | 2 | $37 |
| Alkermes, Inc. | 2 | $35 |
Products named: VRAYLAR, INGREZZA, REXULTI, Auvelity, CAPLYTA, ARISTADA, ABILIFY MAINTENA.
Industry payments across SC — which companies pay providers there.
